Cargando…

pH sensitive peptide functionalized nanoparticles for co-delivery of erlotinib and DAPT to restrict the progress of triple negative breast cancer

Although a variety of drug delivery strategies have been designed for enhancing the treatment of Triple negative breast cancer (TNBC), combating with TNBCs is still dramatically challenged by the selection of appropriate therapeutic targets and insufficient tumor accumulation or inner penetration of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wan, Xu, Liu, Chaoqian, Lin, Yinan, Fu, Jie, Lu, Guohong, Lu, Zhengmao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462792/ https://www.ncbi.nlm.nih.gov/pubmed/30957572 http://dx.doi.org/10.1080/10717544.2019.1576801

Ejemplares similares

The Cornelian dilemma(†) of quitting DAPT
por: Motovska, Zuzana, et al.
Publicado: (2021)

Correlations of DAPT score and PRECISE-DAPT score with the extent of coronary stenosis in acute coronary syndrome
por: Long, Tianyi, et al.
Publicado: (2018)

Contradictions between DAPT and PRECISE-DAPT scores with the severity of coronary lesion in acute coronary syndrome
por: Bi, Sisi, et al.
Publicado: (2020)

A comparison of safety and efficacy between long-term DAPT and intensive statins combined with short-term DAPT for acute ischemic stroke
por: Deng, Ting, et al.
Publicado: (2023)

The effects of dual antiplatelet therapy (DAPT) adherence on survival in patients undergoing revascularization and the determinants of DAPT adherence
por: Zhang, Shuqi, et al.
Publicado: (2022)

Short versus prolonged dual antiplatelet therapy (DAPT) duration after coronary stent implantation: A comparison between the DAPT study and 9 other trials evaluating DAPT duration
por: Toyota, Toshiaki, et al.
Publicado: (2017)

Transcytosable Peptide-Paclitaxel Prodrug Nanoparticle for Targeted Treatment of Triple-Negative Breast Cancer
por: Wang, Longkun, et al.
Publicado: (2023)

Timely Inhibition of Notch Signaling by DAPT Promotes Cardiac Differentiation of Murine Pluripotent Stem Cells
por: Liu, Yinan, et al.
Publicado: (2014)

Yiqi Formula Enhances the Antitumor Effects of Erlotinib for Treatment of Triple-Negative Breast Cancer Xenografts
por: Liao, Ming-juan, et al.
Publicado: (2014)

Involvement of the AKT Pathway in Resistance to Erlotinib and Cabozantinib in Triple-Negative Breast Cancer Cell Lines
por: Lefebvre, Cory, et al.
Publicado: (2023)

Redox-responsive and pH-sensitive nanoparticles enhanced stability and anticancer ability of erlotinib to treat lung cancer in vivo
por: Tan, Sheng, et al.
Publicado: (2017)

Formal comment to Toyota et al.: Short versus prolonged dual antiplatelet therapy (DAPT) duration after coronary stent implantation: A comparison between the DAPT study and 9 other trials evaluating DAPT duration
por: Elmariah, Sammy
Publicado: (2017)

DAPT Enhances the Apoptosis of Human Tongue Carcinoma Cells
por: Grottkau, Brian E, et al.
Publicado: (2009)

Should the findings of the DAPT trial change my practice?
Publicado: (2016)

Gastric cancer cell growth and epithelial-mesenchymal transition are inhibited by γ-secretase inhibitor DAPT
por: LI, LU-CHUN, et al.
Publicado: (2014)

Perlecan-targeted nanoparticles for drug delivery to triple-negative breast cancer
por: Khanna, Vidhi, et al.
Publicado: (2019)

pH-Responsive Hyaluronic Acid Nanoparticles for Enhanced Triple Negative Breast Cancer Therapy
por: Zeng, Xiangle, et al.
Publicado: (2022)

Applicability of the PRECISE-DAPT score in elderly patients with myocardial infarction
por: Guerrero, Carme, et al.
Publicado: (2018)

DAPT: A package enabling distributed automated parameter testing
por: Duggan, Ben, et al.
Publicado: (2021)

Short-term DAPT after coronary stenting has similar ischemic and bleeding outcomes as long-term DAPT: a 5-year population-based cohort study
por: Balaji Srinivasan, Sriraag, et al.
Publicado: (2022)

pH-Sensitive Chitosan Nanoparticles for Salivary Protein Delivery
por: Zhu, Yi, et al.
Publicado: (2021)

pH-sensitive dual drug loaded janus nanoparticles by oral delivery for multimodal analgesia
por: Liu, Lin, et al.
Publicado: (2021)

DAPT in the control of human hair follicle stem cell proliferation and differentiation
por: Jiang, Jindou, et al.
Publicado: (2014)

Risk prediction of bleeding and MACCE by PRECISE-DAPT score post-PCI
por: Dannenberg, Lisa, et al.
Publicado: (2021)

Validation of the 4‐Item PRECISE‐DAPT Score: A SWEDEHEART Study
por: Wester, Axel, et al.
Publicado: (2021)

VEGF combined with DAPT promotes tissue regeneration and remodeling in vascular grafts
por: Yang, Tao, et al.
Publicado: (2023)

Biomimetic oxygen delivery nanoparticles for enhancing photodynamic therapy in triple-negative breast cancer
por: Fang, Hanyi, et al.
Publicado: (2021)

Synergistically Enhanced Inhibitory Effects of Pullulan Nanoparticle-Mediated Co-Delivery of Lovastatin and Doxorubicin to Triple-Negative Breast Cancer Cells
por: Wu, Di, et al.
Publicado: (2019)

Peptide Nanoparticle-Mediated Combinatorial Delivery of Cancer-Related siRNAs for Synergistic Anti-Proliferative Activity in Triple Negative Breast Cancer Cells
por: Egorova, Anna, et al.
Publicado: (2021)

Metabolic Response of Triple-Negative Breast Cancer to Folate Restriction
por: Coleman, Michael F., et al.
Publicado: (2021)

Establishing the promising role of novel combination of triple therapeutics delivery using polymeric nanoparticles for Triple negative breast cancer therapy
por: Misra, Ranjita, et al.
Publicado: (2021)

Effect of DAPT, a gamma secretase inhibitor, on tumor angiogenesis in control mice
por: Kalantari, Elmira, et al.
Publicado: (2013)

Notch signaling inhibitor DAPT provides protection against acute craniocerebral injury
por: Zhang, Hong-Mei, et al.
Publicado: (2018)

Rhamnolipid-coated W/O/W double emulsion nanoparticles for efficient delivery of doxorubicin/erlotinib and combination chemotherapy
por: Lee, Yeeun, et al.
Publicado: (2021)

A Dual-Mode Imaging Nanoparticle Probe Targeting PD-L1 for Triple-Negative Breast Cancer
por: Li, Xiajin, et al.
Publicado: (2022)

Co-delivery of gambogic acid and TRAIL plasmid by hyaluronic acid grafted PEI-PLGA nanoparticles for the treatment of triple negative breast cancer
por: Wang, Shengpeng, et al.
Publicado: (2017)

Treating triple negative breast cancer cells with erlotinib plus a select antioxidant overcomes drug resistance by targeting cancer cell heterogeneity
por: Bao, Bin, et al.
Publicado: (2017)

KLF4 defines the efficacy of the epidermal growth factor receptor inhibitor, erlotinib, in triple-negative breast cancer cells by repressing the EGFR gene
por: Roberts, Melyssa S., et al.
Publicado: (2020)

Lipid-Based Nanoparticles as a Pivotal Delivery Approach in Triple Negative Breast Cancer (TNBC) Therapy
por: Chaudhuri, Aiswarya, et al.
Publicado: (2022)

Notch pathway inhibitor DAPT enhances Atoh1 activity to generate new hair cells in situ in rat cochleae
por: Luo, Wen-wei, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0k5r2urgk4la53ore4m3je0ud9